/
Globe Life and the Company refer to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and its subsidiaries and affiliates. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company.
$184.76
+$0.20 (+0.11%)
EOD Jul 17, 2026
19.37% net margin is respectable. The institution appears to be managing its interest spread and credit risk adequately.
Revenue growth slowed to 3.8%, essentially flat. This is a business that needs a catalyst.
Financial stocks carry unique risks (credit cycles, regulatory changes, interest rate sensitivity) that aren't captured by standard quality metrics.
12.8x earnings. In line with financial-sector norms. The question is whether the current credit environment supports sustained earnings at this level.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$6.07B
▲ +3.8% YoY
Net Income (TTM)
$1.18B
▲ +8.4% YoY
Net Margin
19.38%
P/E
12.8x
Balance Sheet
Total Assets
$30.97B
Equity
$6.08B
Total Debt
$2.78B
Cash & Equiv.
$439M
3Y CAGR: +4.7%
Continue Research
At a P/E of 12.8 and a price-to-free-cash-flow of 12.0, Globe Life (GL) trades around a two-stage DCF intrinsic value of about $237.92 per share, so at $184.76 the stock looks around fair value (28.8% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Globe Life scores 87/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 0.6%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $237.92 per share for GL, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $178.44. At today's $184.76, that puts the stock about 28.8% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Globe Life scores 87 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Globe Life pays a regular dividend of about $1.09 per share per year (typically in quarterly installments), a yield of roughly 0.6% at the current price. That is a payout ratio of about 7.4% of earnings, so the dividend is amply covered by earnings. Globe Life has grown the dividend at roughly 1.8% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For GL's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. GL currently trades around its estimated intrinsic value and scores 87/100 on quality (high-quality). It also yields about 0.6%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.